Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Huntington's disease.

Zuccato C, Cattaneo E.

Handb Exp Pharmacol. 2014;220:357-409. doi: 10.1007/978-3-642-45106-5_14. Review.

PMID:
24668480
[PubMed - indexed for MEDLINE]
2.

REST is Present in Human Control and Huntington's Disease Neurons.

Schiffer D, Caldera V, Mellai M, Conforti P, Cattaneo E, Zuccato C.

Neuropathol Appl Neurobiol. 2014 Mar 17. doi: 10.1111/nan.12137. [Epub ahead of print]

PMID:
24634989
[PubMed - as supplied by publisher]
3.

Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, Cattaneo E, Gage FH, Cleveland DW, Glass CK.

Nat Neurosci. 2014 Apr;17(4):513-21. doi: 10.1038/nn.3668. Epub 2014 Mar 2.

PMID:
24584051
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.

Conforti P, Zuccato C, Gaudenzi G, Ieraci A, Camnasio S, Buckley NJ, Mutti C, Cotelli F, Contini A, Cattaneo E.

J Neurochem. 2013 Oct;127(1):22-35. doi: 10.1111/jnc.12348. Epub 2013 Jul 19.

PMID:
23800350
[PubMed - indexed for MEDLINE]
5.

Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.

Breda L, Rivella S, Zuccato C, Gambari R.

Expert Rev Hematol. 2013 Jun;6(3):255-64. doi: 10.1586/ehm.13.24.

PMID:
23782080
[PubMed - indexed for MEDLINE]
6.

Tobramycin is a suppressor of premature termination codons.

Altamura N, Castaldo R, Finotti A, Breveglieri G, Salvatori F, Zuccato C, Gambari R, Panin GC, Borgatti M.

J Cyst Fibros. 2013 Dec;12(6):806-11. doi: 10.1016/j.jcf.2013.02.007. Epub 2013 Mar 27.

PMID:
23540394
[PubMed - in process]
7.

Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts.

Salvador A, Brognara E, Vedaldi D, Castagliuolo I, Brun P, Zuccato C, Lampronti I, Gambari R.

J Photochem Photobiol B. 2013 Apr 5;121:57-66. doi: 10.1016/j.jphotobiol.2013.02.011. Epub 2013 Feb 27.

PMID:
23518160
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.

Conforti P, Mas Monteys A, Zuccato C, Buckley NJ, Davidson B, Cattaneo E.

Gene Ther. 2013 Jun;20(6):678-85. doi: 10.1038/gt.2012.84. Epub 2012 Nov 15.

PMID:
23151521
[PubMed - indexed for MEDLINE]
9.

Pitfalls in the detection of cholesterol in Huntington's disease models.

Marullo M, Valenza M, Leoni V, Caccia C, Scarlatti C, De Mario A, Zuccato C, Di Donato S, Carafoli E, Cattaneo E.

PLoS Curr. 2012 Oct 11;4:e505886e9a1968. doi: 10.1371/505886e9a1968.

PMID:
23145355
[PubMed]
Free PMC Article
10.

Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.

Conforti P, Camnasio S, Mutti C, Valenza M, Thompson M, Fossale E, Zeitlin S, MacDonald ME, Zuccato C, Cattaneo E.

Neurobiol Dis. 2013 Feb;50:160-70. doi: 10.1016/j.nbd.2012.10.015. Epub 2012 Oct 23.

PMID:
23089356
[PubMed - indexed for MEDLINE]
11.

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease.

Pouladi MA, Brillaud E, Xie Y, Conforti P, Graham RK, Ehrnhoefer DE, Franciosi S, Zhang W, Poucheret P, Compte E, Maurel JC, Zuccato C, Cattaneo E, Néri C, Hayden MR.

Neurobiol Dis. 2012 Dec;48(3):282-9. doi: 10.1016/j.nbd.2012.06.026. Epub 2012 Jul 10.

PMID:
22796360
[PubMed - indexed for MEDLINE]
12.

An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.

Lo Sardo V, Zuccato C, Gaudenzi G, Vitali B, Ramos C, Tartari M, Myre MA, Walker JA, Pistocchi A, Conti L, Valenza M, Drung B, Schmidt B, Gusella J, Zeitlin S, Cotelli F, Cattaneo E.

Nat Neurosci. 2012 May;15(5):713-21. doi: 10.1038/nn.3080.

PMID:
22466506
[PubMed - indexed for MEDLINE]
13.

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.

Zuccato C, Breda L, Salvatori F, Breveglieri G, Gardenghi S, Bianchi N, Brognara E, Lampronti I, Borgatti M, Rivella S, Gambari R.

Ann Hematol. 2012 Aug;91(8):1201-13. doi: 10.1007/s00277-012-1430-5. Epub 2012 Mar 31.

PMID:
22460946
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.

Camnasio S, Delli Carri A, Lombardo A, Grad I, Mariotti C, Castucci A, Rozell B, Lo Riso P, Castiglioni V, Zuccato C, Rochon C, Takashima Y, Diaferia G, Biunno I, Gellera C, Jaconi M, Smith A, Hovatta O, Naldini L, Di Donato S, Feki A, Cattaneo E.

Neurobiol Dis. 2012 Apr;46(1):41-51. doi: 10.1016/j.nbd.2011.12.042.

PMID:
22405424
[PubMed - indexed for MEDLINE]
15.

Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.

Fibach E, Prus E, Bianchi N, Zuccato C, Breveglieri G, Salvatori F, Finotti A, Lipucci di Paola M, Brognara E, Lampronti I, Borgatti M, Gambari R.

Int J Mol Med. 2012 Jun;29(6):974-82. doi: 10.3892/ijmm.2012.928. Epub 2012 Feb 28.

PMID:
22378234
[PubMed - indexed for MEDLINE]
16.

Involvement of miRNA in erythroid differentiation.

Bianchi N, Zuccato C, Finotti A, Lampronti I, Borgatti M, Gambari R.

Epigenomics. 2012 Feb;4(1):51-65. doi: 10.2217/epi.11.104. Review.

PMID:
22332658
[PubMed - indexed for MEDLINE]
17.

Brain-derived neurotrophic factor in patients with Huntington's disease.

Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lèvi AC, Tabrizi SJ, Di Donato S, Cattaneo E.

PLoS One. 2011;6(8):e22966. doi: 10.1371/journal.pone.0022966. Epub 2011 Aug 12.

PMID:
21857974
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives.

Romagnoli R, Baraldi PG, Pavani MG, Cruz-Lopez O, Hamel E, Balzarini J, Brognara E, Zuccato C, Gambari R.

Med Chem. 2010 Nov;6(6):329-43.

PMID:
21054275
[PubMed - indexed for MEDLINE]
19.

Molecular mechanisms and potential therapeutical targets in Huntington's disease.

Zuccato C, Valenza M, Cattaneo E.

Physiol Rev. 2010 Jul;90(3):905-81. doi: 10.1152/physrev.00041.2009. Review.

PMID:
20664076
[PubMed - indexed for MEDLINE]
Free Article
20.

Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.

Salvador A, Dall'Acqua S, Sardo MS, Caffieri S, Vedaldi D, Dall'Acqua F, Borgatti M, Zuccato C, Bianchi N, Gambari R.

ChemMedChem. 2010 Sep 3;5(9):1506-12. doi: 10.1002/cmdc.201000204.

PMID:
20645383
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk